Skip to content

Medical Device Forum panel discusses regulatory, supply chain challenges

“Navigating Regulatory and Supply Chain Challenges Today and Tomorrow” was the topic of the May 16 NCBIO Medical Device Luncheon and Forum held at the N.C Biotechnology Center.

The discussion was moderated by Eric Hill, senior director, scientific and technical services for Boston Analytical. The event was sponsored by Clancy & Theys Construction Company, Hughes Pittman & Gupton, Mercury Business Services, UniClean Cleanroom Services and YourBio Health.

To start off, the panelists gave an overview of what was currently happening and most relevant to them in their working environment.

Read More

Panelists offer advice on funding options for emerging companies 

Panelists at the NCBIO Emerging Companies Luncheon and Forum held Wednesday, March 22, at the NC Biotechnology Center offering insight into the way their organizations choose investments, when to seek SBIR funding, engaging with a funding agency for the first time and more.

The forum was sponsored by Clancy & Theys Construction Company, JBK Associates International, Nikon and SAS.

The panel was moderated by Kseniya Simpson, Ph.D., associate, Hatteras Venture Partners.

Read More

BMF meeting explores $25 million Build Back Better grant projects 

At the March 15 meeting the NCBIO Biomanufacturers Forum, attendees received updates on the $25 million Build Back Better Regional Challenge grant awarded in the fall. In September, a statewide coalition of public and private partner organizations and institutions led by NC Biotech and including NCBIO received the award from the U.S. Economic Development Administration’s Build Back Better Regional Challenge. The grant will support a number of life sciences workforce initiatives collectively called Accelerate NC.

Read More

Q&A with the NCBIO Clinical Research Forum panel explores clinical trial barriers 

The panel at the NCBIO Clinical Trials Forum comprised moderater Abby Emanuelson, IQVIA's Erin Finot, Ultragenyx's Julie Harrell and Thermo Fisher Scientific's Rose Blackburne, M.D.

An expert panel explored the current state of clinical trial participation at the NCBIO Clinical Research Forum held Tuesday, Nov. 29. Panelists talked about ways to lower the barriers that stop patients from participating in clinical trials and discussed strategies for achieving diversity. They also explored the role of patient advocates and gave special consideration to efforts focused on rare diseases. 

Read More